{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:34:27Z","timestamp":1791344067714,"version":"4.3.1"},"reference-count":35,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.3892\/ijo.2012.1739","type":"journal-article","created":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T10:58:10Z","timestamp":1355482690000},"page":"721-732","source":"Crossref","is-referenced-by-count":26,"title":["Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death"],"prefix":"10.3892","volume":"42","author":[{"given":"WEI","family":"TIAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YONGCHUAN","family":"DENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LING","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAIFEI","family":"HE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIE","family":"SUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DONG","family":"XU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,12,14]]},"reference":[{"key":"key20180107181109_b1-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2007.11.007","article-title":"Bypassing cancer drug resistance by activating multiple death pathways - a proposal from the study of circumventing cancer drug resistance by induction of necroptosis","volume":"259","author":"Hu","year":"2008","journal-title":"Cancer Lett"},{"key":"key20180107181109_b2-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.canlet.2005.11.031","article-title":"Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7\/ADR by honokiol","volume":"243","author":"Xu","year":"2006","journal-title":"Cancer Lett"},{"key":"key20180107181109_b3-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12033-010-9321-2","article-title":"Multiple drug resistance mechanisms in cancer","volume":"46","author":"Baguley","year":"2010","journal-title":"Mol Biotechnol"},{"key":"key20180107181109_b4-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11670-011-0218-9","article-title":"Curcumin prevents induced drug resistance: a novel function?","volume":"23","author":"Xu","year":"2011","journal-title":"Chin J Cancer Res"},{"key":"key20180107181109_b5-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-60761-416-6_4","article-title":"Mechanisms of multidrug resistance in cancer","volume":"596","author":"Gillet","year":"2010","journal-title":"Methods Mol Biol"},{"key":"key20180107181109_b6-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/cncr.22492","article-title":"A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer","volume":"109","author":"Gandhi","year":"2007","journal-title":"Cancer"},{"key":"key20180107181109_b7-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00280-009-0925-9","article-title":"A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen","volume":"64","author":"Ruff","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107181109_b8-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cdd.2008.150","article-title":"Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009","volume":"16","author":"Kroemer","year":"2009","journal-title":"Cell Death Differ"},{"key":"key20180107181109_b9-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-06-3818","article-title":"Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107181109_b10-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.canlet.2008.09.029","article-title":"Naturally-occurring shikonin analogues - a class of necroptotic inducers that circumvent cancer drug resistance","volume":"274","author":"Xuan","year":"2009","journal-title":"Cancer Lett"},{"key":"key20180107181109_b11-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"e5493","DOI":"10.1371\/journal.pone.0005493","article-title":"The necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells","volume":"4","author":"Guidicelli","year":"2009","journal-title":"PLoS One"},{"key":"key20180107181109_b12-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1182\/blood-2005-01-0346","article-title":"Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis","volume":"106","author":"Ishitsuka","year":"2005","journal-title":"Blood"},{"key":"key20180107181109_b13-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/15376511003758831","article-title":"Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells","volume":"20","author":"Wang","year":"2010","journal-title":"Toxicol Mech Methods"},{"key":"key20180107181109_b14-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3748\/wjg.v10.i15.2205","article-title":"Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO","volume":"10","author":"Wang","year":"2004","journal-title":"World J Gastroenterol"},{"key":"key20180107181109_b15-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.3748\/wjg.v10.i23.3459","article-title":"Honokiol: a potent chemotherapy candidate for human colorectal carcinoma","volume":"10","author":"Chen","year":"2004","journal-title":"World J Gastroenterol"},{"key":"key20180107181109_b16-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"key20180107181109_b17-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-1-61779-080-5_34","article-title":"Analysis of drug interactions","volume":"731","author":"Bijnsdorp","year":"2011","journal-title":"Methods Mol Biol"},{"key":"key20180107181109_b18-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1182\/blood-2004-11-4273","article-title":"The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells","volume":"106","author":"Battle","year":"2005","journal-title":"Blood"},{"key":"key20180107181109_b19-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/sj.leu.2404692","article-title":"ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?","volume":"21","author":"Steinbach","year":"2007","journal-title":"Leukemia"},{"key":"key20180107181109_b20-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tibs.2006.11.001","article-title":"Cell death by necrosis: towards a molecular definition","volume":"32","author":"Golstein","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"key20180107181109_b21-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: an ordered cellular explosion","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107181109_b22-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrm2393","article-title":"Expansion and evolution of cell death programmes","volume":"9","author":"Degterev","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107181109_b23-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbamcr.2010.09.013","article-title":"Is mPTP the gatekeeper for necrosis, apoptosis, or both?","volume":"1813","author":"Kinnally","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key20180107181109_b24-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-kappaB signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat Immunol"},{"key":"key20180107181109_b25-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/cr.2010.161","article-title":"A single NFkappaB system for both canonical and non-canonical signaling","volume":"21","author":"Shih","year":"2011","journal-title":"Cell Res"},{"key":"key20180107181109_b26-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"key20180107181109_b27-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.1038\/sj.onc.1204926","article-title":"Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer","volume":"20","author":"Catz","year":"2001","journal-title":"Oncogene"},{"key":"key20180107181109_b28-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1074\/jbc.274.13.8531","article-title":"Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons","volume":"274","author":"Tamatani","year":"1999","journal-title":"J Biol Chem"},{"key":"key20180107181109_b29-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1038\/sj.onc.1205848","article-title":"The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis","volume":"21","author":"Dong","year":"2002","journal-title":"Oncogene"},{"key":"key20180107181109_b30-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.onc.1206056","article-title":"NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells","volume":"22","author":"Bentires-Alj","year":"2003","journal-title":"Oncogene"},{"key":"key20180107181109_b31-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"e21573","DOI":"10.1371\/journal.pone.0021573","article-title":"Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells","volume":"6","author":"Arora","year":"2011","journal-title":"PLoS One"},{"key":"key20180107181109_b32-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/1541-7786.MCR-06-0076","article-title":"Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway","volume":"4","author":"Ahn","year":"2006","journal-title":"Mol Cancer Res"},{"key":"key20180107181109_b33-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.bcp.2005.08.011","article-title":"Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation","volume":"70","author":"Tse","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"key20180107181109_b34-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.onc.1204168","article-title":"Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin","volume":"20","author":"Arlt","year":"2001","journal-title":"Oncogene"},{"key":"key20180107181109_b35-ijo-42-02-0721","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrc1588","article-title":"Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs","volume":"5","author":"Nakanishi","year":"2005","journal-title":"Nat Rev Cancer"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2012.1739\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T18:13:36Z","timestamp":1515348816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2012.1739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,14]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,12,14]]},"published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.3892\/ijo.2012.1739"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2012.1739","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,14]]}}}